<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1789-1497'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/profile/">Profile</a>
<span>IHC - Microsatellite Instability Panel for Colorectal Carcinoma (MLH-1, MSH-2, MSH- 6, PMS-2)</span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">IHC - Microsatellite Instability Panel for Colorectal Carcinoma (MLH-1, MSH-2, MSH- 6, PMS-2)</h1>
<div class="post-text">
<p>The <strong>Immunohistochemistry (IHC) - Microsatellite Instability Panel</strong> for Colorectal Carcinoma is a diagnostic test that uses tissue samples to identify changes in proteins produced by MLH1, MSH2, MSH6, and PMS2 genes. These genes are key components of the DNA mismatch repair (MMR) system, which works to fix mistakes that can occur when DNA is copied during cell division.</p>
<p>Mutations in any of these genes can disrupt the normal functioning of the MMR system, causing a phenomenon known as microsatellite instability (MSI). This instability, characterized by changes in the length of DNA sequences called microsatellites, is a common feature of several types of cancer, including colorectal cancer.</p>
<p>The <strong>IHC - Microsatellite Instability Panel</strong> is a crucial test for the evaluation and management of colorectal cancer. It can aid in determining the likelihood of the disease, particularly in individuals with a family history of colorectal cancer or other risk factors. The results can also guide treatment options, as cancers with high microsatellite instability (MSI-H) often respond differently to certain therapies compared to cancers with low MSI (MSI-L) or those that are microsatellite stable (MSS).</p>

<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Profile Name</th>
			<td scope="col">IHC - Microsatellite Instability Panel for Colorectal Carcinoma (MLH-1, MSH-2, MSH- 6, PMS-2)</td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Tissue</td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No specific instructions required. Continue with your normal diet and medications unless told otherwise by your doctor.</td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>4 days</td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 6900</td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3">Why is the IHC - Microsatellite Instability Panel test important?</h2>
<p>The <strong>IHC - Microsatellite Instability Panel test</strong> is vital as it helps identify changes in proteins involved in DNA
    mismatch repair. These changes can lead to microsatellite instability, a characteristic feature of several types of
    cancers, including colorectal cancer.</p>
<h2 class="test-h2 mt-3">What does a positive result mean?</h2>
<p>A positive result indicates that one or more of the proteins are not functioning normally, suggesting the possibility
    of colorectal cancer.</p>
<!--section achieved-->
<?php include "../../include/iconsbox.php" ?>
<!--//section achieved-->

<h2 class="test-h2 mt-3">What does a negative result mean?</h2>
<p>A negative result suggests that the proteins are functioning normally, reducing the likelihood of colorectal cancer.
    However, it doesn't entirely rule out the presence of cancer.</p>
<h2 class="test-h2 mt-3">Who should get this test?</h2>
<p>This test is often recommended for individuals with a family history of colorectal cancer or other risk factors. It
    can also guide treatment decisions for individuals diagnosed with colorectal cancer.</p>
<h2 class="test-h2 mt-3">How is the test performed?</h2>
<p>The test is performed on a tissue sample, typically obtained through a biopsy. The sample is then stained with
    specific antibodies that bind to the proteins and analyzed under a microscope.</p>
<h2 class="test-h2 mt-3">Can this test detect other types of cancer?</h2>
<p>While this test is primarily used to identify colorectal cancer, changes in these proteins can also occur in other
    cancers, such as endometrial cancer. Therefore, the test may provide useful information in other contexts.</p>
<h2 class="test-h2 mt-3">Is fasting required for this test?</h2>
<p>No, fasting is not required for this test.</p>
<h2 class="test-h2 mt-3">Are there any risks associated with this test?</h2>
<p>The test itself doesn't pose any risks. However, obtaining the tissue sample for testing can involve some risks,
    depending on the biopsy method used.</p>
<h2 class="test-h2 mt-3">Are there any factors that can affect the test results?</h2>
<p>The quality of the tissue sample and the specific method used for staining and observation can potentially affect the
    test results.</p>
<h2 class="test-h2 mt-3">What should I do if my test results are abnormal?</h2>
<p>If your test results are abnormal, it's important to discuss the findings with your doctor, who can provide further
    guidance based on your overall health, <a href="https://www.sprintdiagnostics.in/symptoms"><b style="color:#2C53A5">symptoms</b></a>, and other diagnostic tests.</p>
<h2 class="test-h2 mt-3">How often should this test be performed?</h2>
<p>The frequency of this test varies and will be determined by your healthcare provider, depending on your specific
    situation.</p>
<h2 class="test-h2 mt-3">Is this test covered by insurance?</h2>
<p>Coverage for this test will depend on your specific insurance plan. It is recommended to check with your insurance
    provider for coverage details.</p>
<h2 class="test-h2 mt-3">Are there any alternatives to this test?</h2>
<p>There are other types of genetic testing that can provide information about the likelihood of colorectal cancer.
    However, the IHC - Microsatellite Instability Panel is unique in its ability to examine the function of multiple key
    proteins at once.</p>
<h2 class="test-h2 mt-3">Can a normal result guarantee I don't have colorectal cancer?</h2>
<p>A normal result can't guarantee the absence of colorectal cancer. It only suggests that the proteins are functioning
    normally and there is no microsatellite instability. Other diagnostic tests may be necessary.</p>
<h2 class="test-h2 mt-3">Who should I consult in case of abnormal results?</h2>
<p>If your results are abnormal, it's best to consult an oncologist or a genetic counselor who can interpret the results and guide you about the next steps.</p>
<p>In conclusion, the <strong>IHC - Microsatellite Instability </strong> for Colorectal Carcinoma is a vital tool in the fight against colorectal cancer. It not only helps in the detection and management of the disease but also aids in understanding the genetic basis of cancer development, enabling a more personalized approach to patient care.</p>




</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>